Low grade chronic inflammation in women with polycystic ovarian syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 6, 2001, Pages 2453-2455

  Kelly, Chris C J ^a   Lyall, Helen ^a   Petrie, John R ^a   Gould, Gwyn W ^a   Connell, John M C ^a   Sattar, Naveed ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MENSTRUAL CYCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

FALLOPIA;

EID: 0034971531     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.6.7580     Document Type: Article

References (27)

1. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
2. The long term health consequences of polycystic ovary syndrome
3. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
4. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tollerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
5. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin dependent diabetes mellitus
6. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome
7. Clinical signs of androgen excess as risk factors for coronary artery disease
8. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization
9. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
10. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
11. C-Reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
12. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
13. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): A cohort study
14. The determinants of diabetes in the WOSCOPS cohort study
15. Glucose clamp technique: A method for quantifying insulin secretion and resistance
16. A solid phase enzyme immunoassay for C-reactive protein: Clinical value and the effect of rheumatoid factor
17. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
18. Production of C-reactive protein and risk of coronary events in stable and unstable angina
19. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
20. Abdominal obesity: The critical correlate of elevated plasma C-reactive protein levels associated with features of the insulin resistance syndrome in men
21. Anthropometric variables and metabolism in polycystic ovarian disease
22. Lipids and lipoprotein subfractions in women with PCOS
23. Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: A nested case-referent study in the DOM-cohort
24. Direct proinflammatory effect of C-reactive protein on human endothelial cells
25. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
26. Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries
27. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome